Current Headlines

  1. Philips HealthTech’s Q3 Boosted By Growing Order Intake, Stepped-Up R&D

    Royal Philips' successful pivot into health technology continues with third quarter sales surging 14 percent to ‎€5.9 billion ($6.4B), primarily driven by 5 percent comparable sales growth and an 8 percent hike in order intake in its HealthTech portfolio.

  2. GE Healthcare Rides Imaging, Chinese Market To “Another Solid Quarter” Of Growth

    GE Healthcare continues to grow in its third quarter of 2016, and the company posted double-digit profit growth for its healthcare business despite substantial challenges in other segments, principally oil and gas. Senior executives attribute 8 percent growth in overall healthcare orders to strength in imaging and continued momentum in the Chinese market.

  3. Phillips-Medisize To Participate In Panel At Partnership Opportunities In Drug Delivery (PODD)

    Phillips-Medisize Corporation, is once again a sponsor and will present during a panel discussion at the upcoming Partnership Opportunities in Drug Delivery (PODD) conference in Boston, MA.

  4. FDA Seeks Input On Emerging Sciences And Technologies

    The U.S. Food and Drug Administration (FDA) is asking scientists and technology experts from the private sector to provide the agency with valuable input on emerging issues and cross-cutting scientific advances that could impact regulation within five to 10 years.

  5. Stretchy Optical Fibers Could Detect Disease

    Optical fibers designed using biocompatible hydrogel could play a role in next-generation, flexible biosensors, according to scientists at Harvard University and MIT. By tracking the quality of light shining through the stretchy fibers, researchers could use the technology in implantable or wearable devices to monitor muscle mobility, tumor growth, or inflammation over time.

  6. New Size Of Medtronic’s Directional Atherectomy System Cleared By FDA

    Medtronic plc has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne Directional Atherectomy System in a new size for treating patients with peripheral artery disease (PAD).

  7. New Baxter Dialysis Solution’s Filtration “More Closely Mimics The Natural Kidney”

    Baxter International Inc., a leader in developing technologies that transform renal care, recently announced the global launch of HDx enabled by THERANOVA, a new type of hemodialysis (HD) therapy that provides high performance treatments with integration into existing healthcare infrastructure.

  8. Abbott CEO “Bullish” On St. Jude, Guarded On Alere Deal

    Abbott CEO Miles White says the deal to acquire St. Jude Medical is on track to close by the end the year, as expected. The planned purchase of point-of-care diagnostics firm Alere, however, needs to comply with certain regulatory requirements, which Abbott is actively pursuing.

  9. 3D-Printed Biodegradable Stents Bypass Traditional Stent Complications

     According to researchers, the citrus-based polymer material used has natural antioxidant properties, and could potentially be loaded with anti-coagulation drugs to minimize complications.

  10. Intuitive Surgical Developing "Variety Of Technologies" To Enhance Robotic Surgery Platform

    Third quarter profit for Intuitive Surgical surged 26 percent on increased procedures and sales of its da Vinci surgical platform, which the company is looking to expand by bringing in new technologies through a combination of in-house R&D, partnerships, licensing, and tuck-in acquisitions.